IL-15 to boost HIV control after pausing daily meds
Treatments studied
Part of Infections clinical trials.
This study tests whether giving a small protein called IL-15 can help your immune system keep HIV under control after pausing your daily HIV medications. You will stop your meds for a short time under careful monitoring, and the hope is that your body might learn to fight HIV without daily pills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old and have documented HIV-1 infection.
- You have been taking daily HIV medication (ART) for at least the past 6 months with no breaks longer than 2 weeks in a row.
- Your HIV viral load has been low (under 200 copies/mL) for the past 6 months.
- Your CD4 count (a measure of immune health) is 350 or higher.
- You are willing to temporarily stop your HIV medications during the study (a planned treatment interruption).
- You have not received long-acting injectable HIV medications in the last 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of powerful antibodies (bNAbs) can help control HIV after stopping standard HIV treatment. Participants will pause their daily HIV medications while receiving these antibodies, and doctors will closely monitor their immune system and virus levels. It's for people who are already well-controlled on HIV treatment and have participated in a specific earlier study.
This trial tests whether you can safely stop your HIV medication for a while if your immune system has specific markers that might help control the virus. The goal is to see if a treatment pause could be an option for people like you.
This Phase 1 trial tests two new HIV vaccines (DV700P-RNA and DV701B1.1-RNA) combined with a monitored break from HIV medications in people with well-controlled HIV. The goal is to see if this approach safely strengthens the immune system's ability to fight HIV.
This study tests a medicine called IL-7 (interleukin-7) that may help raise the number of CD4 cells (a type of immune cell) in people with HIV whose CD4 counts stay low despite effective HIV treatment. The goal is to see if it can improve immune function and potentially reduce infection risk.
This study looks at whether some people with HIV can keep the virus controlled even if they temporarily stop HIV medicines (an “analytic treatment interruption”). If you qualify, it may help researchers learn what it would take for an HIV cure.
This Phase 2 study uses special scans (PET/CT) and tissue sampling (biopsy) to learn what is happening in the body while people with HIV take a planned break from antiretroviral therapy (ART) for up to 90 days. It may help researchers find better ways to control HIV without ongoing treatment, though joining involves careful monitoring during the pause.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.